Search Results - "Mason, Meredith C."

Preoperative Cancer Cachexia and Short-term Outcomes Following Surgery by Mason, Meredith C., MD, Garcia, Jose M., MD, PhD, Sansgiry, Shubhada, PhD, Walder, Annette, MS, Berger, David H., MD, MHCM, Anaya, Daniel A., MD

“…Abstract Background Cancer cachexia is an important measure of physiologic reserve associated with worse survival, and represents an actionable factor for the…”
Get full text

The seven attributes of the academic surgeon: Critical aspects of the archetype and contributions to the surgical community by Rosengart, Todd K., MD, Mason, Meredith C., MD, LeMaire, Scott A., MD, Brandt, Mary L., MD, Coselli, Joseph S., MD, Curley, Stephen A., MD, Mattox, Kenneth L., MD, Mills, Joseph L., MD, Sugarbaker, David J., MD, Berger, David A., MD

“…Abstract Background “Academic surgeon” describes a member of a medical school department of surgery, but this term does not fully define the important role of…”
Get full text

Condyloma lata mimicking vulvar carcinoma in an immunocompromised patient: A case report by Thayer, Elizabeth G., Roecker, Zoe A., Van Smaalen, Kevin M., Mason, Meredith C., Modesitt, Susan C.

“…•Syphilis is increasing in incidence and can present with atypical vulvar lesions suspicious for dysplasia or carcinoma.•Syphilis should be considered when…”
Get full text

Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening by Izzo, Francesco, Mason, Meredith C, Silberfein, Eric J, Massarweh, Nader N, Hsu, Cary, Tran Cao, Hop S, Palaia, Raffaele, Piccirillo, Mauro, Belli, Andrea, Patrone, Renato, Fusco, Roberta, Granata, Vincenza, Curley, Steven A

“…Background: We initiated a prospective screening trial in patients with hepatitis to diagnose HCC in the early stage and to evaluate the impact on long-term…”
Get full text

Volume-Outcome for Pancreatic Cancer: Finally Getting Under the Hood by Mason, Meredith C., Massarweh, Nader N.

Get full text

Ford Versus Ferrari: Novel Technologies in the Setting of a Reliable Standard by Delman, Keith A., Mason, Meredith C., Lowe, Michael C.

Get full text

ASO Author Reflections: Role of Neoadjuvant Therapy in Surgically Resectable Intrahepatic Cholangiocarcinoma by Mason, Meredith C., Tran Cao, Hop S.

Get full text

Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience by Mason, Meredith C., Massarweh, Nader N., Tzeng, Ching-Wei D., Chiang, Yi-Ju, Chun, Yun Shin, Aloia, Thomas A., Javle, Milind, Vauthey, Jean-Nicolas, Tran Cao, Hop S.

“…Background While surgery is a mainstay of curative-intent treatment for patients with intrahepatic cholangiocarcinoma (IHC), the role of neoadjuvant therapy…”
Get full text

Effect of Minimally Invasive Gastrectomy on Return to Intended Oncologic Therapy for Gastric Cancer by Koo, Andee, Mavani, Parit T., Sok, Caitlin, Goyal, Subir, Concors, Seth, Mason, Meredith C., Winer, Joshua H., Russell, Maria C., Cardona, Kenneth, Lin, Edward, Maithel, Shishir K., Kooby, David A., Staley, Charles A., Shah, Mihir M.

“…Adjuvant chemotherapy offers survival benefit to patients with gastric cancer. Only 50-65% of patients who undergo neoadjuvant chemotherapy and gastrectomy are…”
Get full text

Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases by Mason, Meredith C., Tzeng, Ching-Wei D., Tran Cao, Hop S., Aloia, Thomas A., Newhook, Timothy E., Overman, Michael J., Kopetz, Scott E., Vauthey, Jean-Nicolas, Chun, Yun Shin

“…Liquid biopsies are increasingly tested in patients with colorectal cancer to assess tumor burden, response to therapy, and prognosis. The significance of…”
Get full text

Implementation of a Hepatocellular Carcinoma Screening Program for At-risk Patients Safety-Net Hospital: A Model for National Dissemination by Lee, Rachel M., Darby, Rapheisha, Medin, Caroline R., Haser, Grace C., Mason, Meredith C., Miller, Lesley S., Staley, Charles A., Maithel, Shishir K., Russell, Maria C.

“…Objective: This study aimed to enhance hepatocellular carcinoma (HCC) screening to achieve earlier diagnosis of patients with hepatitis C (HCV) cirrhosis in…”
Get full text

Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases by Nishioka, Yujiro, Chun, Yun Shin, Overman, Michael J, Cao, Hop S Tran, Tzeng, Ching-Wei D, Mason, Meredith C, Kopetz, Scott W, Bauer, Todd W, Vauthey, Jean-Nicolas, Newhook, Timothy E

“…Circulating tumor DNA (ctDNA) is a promising biomarker for patients undergoing hepatectomy for colorectal liver metastases (CLM). We hypothesized that…”
Get full text

Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection by Mason, Meredith C., Krasnodebski, Maciej, Hester, Caitlin A., Kothari, Anai N., Barker, Caeli, Nishioka, Yujiro, Chiang, Yi-Ju, Newhook, Timothy E., Tzeng, Ching-Wei D., Chun, Yun Shin, Vauthey, Jean-Nicolas, Tran Cao, Hop S.

“…Background Pathologic response to preoperative chemotherapy predicts survival in patients with colorectal liver metastases (CLMs) who undergo hepatectomy. In…”
Get full text

Adjuvant Therapy for Pancreatic Adenocarcinoma-Leaving No Rock Unturned by Mason, Meredith C, Russell, Maria C, Massarweh, Nader N

Get more information

Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer by Mason, Meredith C, Tran Cao, Hop S, Awad, Samir S, Farjah, Farhood, Chang, George J, Massarweh, Nader N

“…OBJECTIVE:The aim of the study was to evaluate the impact of receiving care at high minimally invasive surgery (MIS)-utilizing hospitals BACKGROUND:MIS…”
Get full text

ASO Visual Abstract: Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection by Mason, Meredith C., Krasnodebski, Maciej, Hester, Caitlin A., Kothari, Anai N., Barker, Caeli, Nishioka, Yujiro, Chiang, Yi-Ju, Newhook, Timothy E., Tzeng, Ching-Wei D., Chun, Yun Shin, Vauthey, Jean-Nicolas, Tran Cao, Hop S.

Get full text

Post‐embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma by Mason, Meredith C, Massarweh, Nader N, Salami, Aitua, Sultenfuss, Mark A, Anaya, Daniel A

“…Abstract Background Transarterial chemoembolization (TACE) is the most common treatment for patients with unresectable hepatocellular carcinoma (HCC)…”
Get full text

National Quality Forum Colon Cancer Quality Metric Performance: How Are Hospitals Measuring Up? by Mason, Meredith C, Chang, George J, Petersen, Laura A, Sada, Yvonne H, Tran Cao, Hop S, Chai, Christy, Berger, David H, Massarweh, Nader N

“…OBJECTIVE:To evaluate the impact of care at high-performing hospitals on the National Quality Forum (NQF) colon cancer metrics. BACKGROUND:The NQF endorses…”
Get full text

Variation in postacute care utilization after complex surgery by Balentine, Courtney J., Mason, Meredith C., Richardson, Peter J., Kougias, Panagiotis, Bakaeen, Faisal, Naik, Aanand D., Berger, David H., Anaya, Daniel A.

“…Variation in use of postacute care (PAC), including skilled nursing facilities and inpatient rehabilitation, accounts for 73% of regional variation in Medicare…”
Get full text

Postacute Care and Recovery After Cancer Surgery: Still a Long Way to Go by Balentine, Courtney J, Richardson, Peter A, Mason, Meredith C, Naik, Aanand D, Berger, David H, Anaya, Daniel A

“…To determine whether postacute care (PAC) facilities can compensate for increased mortality stemming from a complicated postoperative recovery (complications…”
Get full text